A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

Moderna stock is up 663% in 2026, beating AI names for the S&P 500 lead. Full cancer vaccine data arrives October 24.

Oct 11, 2026 - 03:00
 0  1
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Moderna stock is up 663% in 2026, beating AI names for the S&P 500 lead. Full cancer vaccine data arrives October 24.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow